caa a22 4500 445332514 CHVBK 20180317142742.0 cr unu---uuuuu 170323e20111001xx s 000 0 eng 10.1007/s10198-010-0261-3 doi (NATIONALLICENCE)springer-10.1007/s10198-010-0261-3 Atrial fibrillation: the cost of illness in Sweden [Elektronische Daten] [Lisa Ericson, Lennart Bergfeldt, Ingela Björholt] Aim: To provide an estimate of the annual cost of atrial fibrillation (AF) in Sweden. Methods: Prevalence-based cost analysis of AF in Sweden for 2007. Direct medical (hospitalizations, hospital outpatient care, primary health care, non-pharmacological interventions, pharmaceuticals, and anticoagulation monitoring) and non-medical (transportation associated with health care visits) costs of AF, direct costs of AF complications (stroke and heart failure), and indirect costs (production loss), were included. Data were based on Swedish registries, reports and databases, published literature, and an expert panel. Results: There were 100,557 individuals with AF as primary or secondary diagnosis that were either hospitalized or treated in hospital outpatient care in 2007. The total cost of AF was estimated at €708 million. The major cost driver was the direct cost of complications (54%), followed by hospitalization due to AF including AF as secondary diagnosis (18%), and production loss (12%). Conclusion: This is a comprehensive, nation-based cost analysis of AF where relevant data were derived from national registries covering the entire Swedish population. The results showed that the annual cost of AF was high in comparison with other diseases, but likely to be underestimated as a conservative approach was applied in the analysis. The Author(s), 2010 Cost of illness nationallicence Direct costs nationallicence Indirect costs nationallicence Atrial fibrillation nationallicence Stroke nationallicence Heart failure nationallicence Ericson Lisa Nordic Health Economic Research, Sahlgrenska Science Park, Medicinaregatan 8a, 413 46, Gothenburg, Sweden aut Bergfeldt Lennart Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden aut Björholt Ingela Nordic Health Economic Research, Sahlgrenska Science Park, Medicinaregatan 8a, 413 46, Gothenburg, Sweden aut The European Journal of Health Economics Springer-Verlag 12/5(2011-10-01), 479-487 1618-7598 12:5<479 2011 12 10198 https://doi.org/10.1007/s10198-010-0261-3 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10198-010-0261-3 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Ericson Lisa Nordic Health Economic Research, Sahlgrenska Science Park, Medicinaregatan 8a, 413 46, Gothenburg, Sweden aut NATIONALLICENCE 700 1- Bergfeldt Lennart Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden aut NATIONALLICENCE 700 1- Björholt Ingela Nordic Health Economic Research, Sahlgrenska Science Park, Medicinaregatan 8a, 413 46, Gothenburg, Sweden aut NATIONALLICENCE 773 0- The European Journal of Health Economics Springer-Verlag 12/5(2011-10-01), 479-487 1618-7598 12:5<479 2011 12 10198 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer